Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV

ACS Chemical Biology
Hyun LeeMichael E Johnson

Abstract

The Middle East Respiratory Syndrome coronavirus (MERS-CoV) papain-like protease (PLpro) blocking loop 2 (BL2) structure differs significantly from that of SARS-CoV PLpro, where it has been proven to play a crucial role in SARS-CoV PLpro inhibitor binding. Four SARS-CoV PLpro lead inhibitors were tested against MERS-CoV PLpro, none of which were effective against MERS-CoV PLpro. Structure and sequence alignments revealed that two residues, Y269 and Q270, responsible for inhibitor binding to SARS-CoV PLpro, were replaced by T274 and A275 in MERS-CoV PLpro, making critical binding interactions difficult to form for similar types of inhibitors. High-throughput screening (HTS) of 25 000 compounds against both PLpro enzymes identified a small fragment-like noncovalent dual inhibitor. Mode of inhibition studies by enzyme kinetics and competition surface plasmon resonance (SPR) analyses suggested that this compound acts as a competitive inhibitor with an IC50 of 6 μM against MERS-CoV PLpro, indicating that it binds to the active site, whereas it acts as an allosteric inhibitor against SARS-CoV PLpro with an IC50 of 11 μM. These results raised the possibility that inhibitor recognition specificity of MERS-CoV PLpro may differ from that...Continue Reading

References

Aug 15, 2003·The Journal of General Virology·Volker ThielJohn Ziebuhr
Oct 16, 2003·The Journal of Biological Chemistry·Tatiana A ChernovaKeith D Wilkinson
Sep 11, 2004·Current Opinion in Microbiology·John Ziebuhr
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexei A VaginGarib N Murshudov
Sep 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Susanna K P LauKwok-Yung Yuen
Oct 1, 2005·Science·Wendong LiLin-Fa Wang
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Chittaranjan DasGregory A Petsko
Apr 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kiira RatiaAndrew D Mesecar
Dec 16, 2006·Current Pharmaceutical Design·Haitao YangZihe Rao
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kiira RatiaAndrew D Mesecar
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Oct 19, 2012·The New England Journal of Medicine·Ali M ZakiRon A M Fouchier
Oct 19, 2012·The New England Journal of Medicine·Larry J Anderson, Ralph S Baric
Jun 21, 2013·The New England Journal of Medicine·Abdullah AssiriUNKNOWN KSA MERS-CoV Investigation Team
Feb 18, 2014·Acta Crystallographica. Section D, Biological Crystallography·Chi-Yuan ChouYa-Wen Chou

❮ Previous
Next ❯

Citations

Feb 13, 2016·Nature Reviews. Drug Discovery·Alimuddin ZumlaKwok-Yung Yuen
Sep 1, 2015·Experimental & Molecular Medicine·Prasannavenkatesh DuraiSangdun Choi
Apr 20, 2017·Biological & Pharmaceutical Bulletin·Mahmoud Kandeel, Abdallah Altaher
Jan 26, 2017·Expert Opinion on Therapeutic Patents·Jiwon ChoiYoung Bong Kim
Jun 20, 2017·Journal of Molecular Biology·Ben A Bailey-ElkinBrian L Mark
Sep 1, 2017·Journal of Medical Microbiology·Ali A RabaanHatem M Alhani
Feb 28, 2016·Virologica Sinica·Haofeng WangCheng Chen
Mar 28, 2020·Protein Science : a Publication of the Protein Society·Lu WangChengpeng Fan
Aug 21, 2020·MBio·Shin-Ichiro HattoriHiroaki Mitsuya
Aug 28, 2020·Medicinal Research Reviews·Thanigaimalai PillaiyarMaheswaran Easwaran
Aug 28, 2020·The EMBO Journal·Theresa KlemmDavid Komander
Oct 2, 2020·Pharmaceuticals·Anastasiia I Petushkova, Andrey A Zamyatnin
Aug 23, 2017·Expert Review of Respiratory Medicine·Ali A Rabaan
Mar 11, 2020·International Journal of Molecular Sciences·Junyan LinMengyun Wang
Dec 20, 2018·Viruses·Ruiying LiangFei Yu
Aug 28, 2020·Frontiers in Molecular Biosciences·Yuliana K BoskenChia-En A Chang
Nov 18, 2020·Journal of Biomolecular Structure & Dynamics·Dhaval PatelP C Jha
Nov 29, 2020·Expert Opinion on Therapeutic Patents·Clemente CapassoClaudiu T Supuran
Dec 1, 2020·Frontiers in Chemistry·Tamer M IbrahimFrank M Boeckler
Dec 18, 2020·Emerging Microbes & Infections·Mengxia LiGuiqing Peng
Sep 9, 2020·Acta Pharmaceutica Sinica. B·Xiaopan GaoSheng Cui
Dec 1, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiao-Huan LiuTao Wang
Feb 11, 2021·Colloids and Surfaces. A, Physicochemical and Engineering Aspects·Kazushige Yokoyama, Akane Ichiki
Feb 13, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Oksana SytarMarco Landi
Oct 3, 2020·Bioorganic & Medicinal Chemistry·Leandro Rocha SilvaEdeildo Ferreira da Silva-Júnior
Feb 23, 2021·European Journal of Medicinal Chemistry·Sk Abdul AminTarun Jha
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roxanna HajbabaieTaufiq Rahman
Mar 16, 2018·European Journal of Medicinal Chemistry·Anushka C Galasiti KankanamalageWilliam C Groutas
Jun 6, 2021·Cell Chemical Biology·Robert S MaginSara J Buhrlage
Jun 29, 2021·European Physical Journal Plus·Foozieh SohrabiSeyed Masoud Hosseini
Dec 23, 2020·Journal of Proteome Research·Mostafa JamalanFathollah Gholami-Borujeni
Dec 23, 2020·Journal of Natural Products·Mitchell P ChristyWilliam H Gerwick
Sep 28, 2021·Computational and Structural Biotechnology Journal·Yifei WuZhong-Ru Xie
May 20, 2020·Saudi Journal of Biological Sciences·Suriya RehmanEbtesam A Al-Suhaimi

❮ Previous
Next ❯

Methods Mentioned

BETA
deubiquitination
X-ray
Assay
Surface Plasmon Resonance
chip

Software Mentioned

Biacore T200
Sigmaplot
PLpro
SigmaPlot Enzyme Kinetics
Coot
CCP4

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.